With an eye toward identifying areas of underserved medical need and matching capital, Ajax Health closed an oversubscribed $120 million series B financing, attracting a host of new investors. Majority investor KKR and existing investor Aisling Capital also joined the round.

Boston Scientific Corp. has inked an agreement to acquire the rest of Cryterion Medical Inc. it does not own for $202 million in up-front cash. The attraction of Cryterion, of Carlsbad, Calif., is the development of a single-shot cryoablation platform for the treatment of atrial fibrillation (AF). Marlborough, Mass.-based Boston Scientific noted that it has invested in Cryterion since its 2016 inception.

Building on its portfolio strategy discussed earlier this year, Integer Holdings Corp., of Frisco, Texas, wrapped up the previously reported sale of its advanced surgical and orthopedics (AS&O) product lines to Medplast LLC for $600 million in cash. The company said proceeds will go toward reducing debt by about $550 million, with the remaining proceeds used to prepay outstanding term B loans.

Glaukos Corp., of San Clemente, Calif., scored an earlier-than-expected approval for its Istent Inject trabecular micro-bypass system, which is indicated for the reduction of intraocular pressure (IOP) in adult patients with mild-to-moderate primary open-angle glaucoma (POAG) who are undergoing cataract surgery.

Last week was a busy one for makers of diabetes devices, with the FDA expanding the approval of Dublin-based Medtronic plc's Minimed 670G hybrid closed looped system, and San Diego's Tandem Diabetes Care Inc. reporting that it had received the agency's nod for the T:slim X2 insulin pump with Basal-IQ technology.